Skip to content

PEAK PHARMACEUTICALS, INC.: filings

Every PEAK PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 47 filings, each linked to its SEC index.

Filing record ends 2023-02-09

The latest filing in this captured record is a 10-Q filed 2023-02-09. No later filing is in the SEC companyfacts record captured on 2026-09-20. PEAK PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-02-09fiscal Q1 202316330001199835-23-000089
10-K2022-12-19fiscal FY 202216330001199835-22-000838
10-Q2022-12-19fiscal Q3 202220600001199835-22-000836
10-Q2022-12-19fiscal Q2 202216470001199835-22-000834
10-Q2022-12-19fiscal Q1 202216330001199835-22-000832
10-K2022-12-19fiscal FY 202116320001199835-22-000830
10-Q2022-12-19fiscal Q3 202116510001199835-22-000828
10-Q2022-12-19fiscal Q2 202117500001199835-22-000826
10-Q2022-12-19fiscal Q1 202117360001199835-22-000824
10-K2022-12-19fiscal FY 202018360001199835-22-000822
10-Q2022-12-19fiscal Q3 202018550001199835-22-000820
10-Q2022-12-19fiscal Q2 202018510001199835-22-000818
10-Q2022-12-19fiscal Q1 202018370001199835-22-000816
10-K2022-12-19fiscal FY 201919370001199835-22-000814
10-Q2022-12-19fiscal Q3 201818550001199835-22-000812
10-Q2022-12-19fiscal Q2 201818510001199835-22-000810
10-Q2022-12-19fiscal Q1 201817360001199835-22-000808
10-K2022-12-19fiscal FY 201819380001199835-22-000806
10-Q2018-08-13fiscal Q3 201815420001199835-18-000018
10-Q2018-05-14fiscal Q2 201815440001199835-18-000014
10-Q2018-02-15fiscal Q1 201814270001199835-18-000008
10-K2018-01-12fiscal FY 201724480001199835-18-000004
10-Q2017-09-13fiscal Q3 201721640001654954-17-008401
10-Q2017-09-13fiscal Q2 201722660001654954-17-008397
10-Q2017-09-13fiscal Q1 201723460001654954-17-008395
10-K2017-09-13fiscal FY 201624480001654954-17-008392
10-Q2017-09-13fiscal Q3 201626730001654954-17-008390
10-Q2017-09-13fiscal Q2 201626730001654954-17-008385
10-Q2016-02-18fiscal Q1 201619360001137050-16-000211
10-K2016-01-13fiscal FY 201522410001137050-16-000192
10-Q2015-08-13fiscal Q3 201522480001137050-15-000111
10-Q2015-05-15fiscal Q2 201522480001137050-15-000082
10-Q2015-02-17fiscal Q1 201519330001137050-15-000037
10-K2015-01-12fiscal FY 201418320001137050-15-000010
10-Q2014-08-14fiscal Q3 201422510001477932-14-004390
10-Q2014-05-14fiscal Q2 201420580001477932-14-002499
10-Q2014-02-18fiscal Q1 201419440001477932-14-000732
10-K2013-12-27fiscal FY 201320490001477932-13-006197
10-Q2013-07-29fiscal Q3 201316470001477932-13-003364
10-Q2013-05-10fiscal Q2 201315450001477932-13-002270
10-Q2013-01-25fiscal Q1 201314340001477932-13-000373
10-K2012-12-26fiscal FY 201216430001477932-12-004972
10-Q2012-07-27fiscal Q2 201215460001477932-12-002467
10-Q2012-05-14fiscal Q2 201214430001165527-12-000441
10-Q2012-02-08fiscal Q1 201213360001165527-12-000090
10-K2011-12-27fiscal FY 201114370001165527-11-001234
10-Q/A2011-09-08fiscal Q3 201117600001165527-11-000846

Inspect the source

Entity
PEAK PHARMACEUTICALS, INC. / CIK 0001452804
Captured
2026-09-20T09:05:40.595Z
SEC response SHA-256
3fd5eb06bfdebffa42021b094c4c379c1efd3c7143204265bf035090db070211

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001452804.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))